ENDOCRINE CONSULT / PEER REVIEWED

10 (Safe) Ways to Reduce Patients’ Insulin Costs

Author and Disclosure Information

 

References

The affordability of insulins is a potentially uncomfortable but necessary conversation to have with your patient. Providers are one of the best resources for patients who seek relief from financial difficulties. The recommendations discussed here can help providers and patients design a cost-conscious plan for insulin treatment. Although each recommendation is viable, the pros and cons must be weighed on a case-by-case basis. Providers and patients should also pay attention to the Senate Finance Committee’s ongoing discussions and possible resolutions that could result in lower insulin costs. Until legislation that lowers the prices of insulin comes to fruition, however, providers should continue to plan with their patients on how to best get their insulin at the lowest cost.

Test yourself with the poll here.

Pages

Recommended Reading

Oral semaglutide monotherapy delivers HbA1c improvements in type 2 diabetes
Clinician Reviews
Diagnosing and managing diabetes and depression
Clinician Reviews
Diabetic neuropathy: Often silent, often dangerous
Clinician Reviews
Diabetes targets remain elusive for patients
Clinician Reviews
Diabetes effect in heart failure varies by phenotype
Clinician Reviews
Dapagliflozin meets primary endpoint in the DAPA-HF trial
Clinician Reviews
FRAX with BMD may not be accurate for women with diabetes
Clinician Reviews
Farxiga gets Fast Track status from FDA
Clinician Reviews
Weight loss surgery linked to lower CV event risk in diabetes
Clinician Reviews
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug
Clinician Reviews